Clinical Trial Update: Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing adjuvant radiotherapy for esophageal squamous cell carcinoma in the era of immunotherapy; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Adjuvant Radiotherapy | Phase 2 | Status: RECRUITING